Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T ...

CAMBRIDGE, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...

The Elementary to Postsecondary Student Education Dashboard: Enrolments, Graduations and Tuition Fees comprehensive data visualization tool overviews counts of enrolments and graduations for ...

Construct financial models with decades of earnings statistics, ratios and valuation data - all exportable - to drive your trade ideas.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The summative assessment consisting of statistical analyses and theory questions this will require students to demonstrate their knowledge and understanding of advanced statistics by carrying out ...

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...

endpoints for patients with advanced gastric cancer. The disappointing outcome has led the company to halt plans for Phase 3 studies in this indication. Leap Therapeutics reported that while the ...